Major Investor Files to Sell $54M in Hinge Health Stock, Continuing Recent Trend
HNGE has more than doubled off its 52-week low of $30.08.
Summary
A major institutional investor, Insight Venture Partners, plans to sell an additional $54 million in Hinge Health stock, extending a pattern of significant share dispositions that total over $146 million in the last three months.
Key Events · Ownership and Investor Activity · HNGE
-
Intent to Sell Additional Shares
Insight Venture Partners (Cayman) X, L.P., a 10% stockholder, filed a Form 144 indicating intent to sell 600,613 shares of Class A common stock, valued at approximately $54.06 million.
-
Continuation of Recent Selling Trend
This proposed sale adds to 1,201,226 shares already sold by the same entity in the past three months, generating gross proceeds of $92.56 million. The total recent selling activity by Insight Venture Partners amounts to over $146 million.
-
Stock Trading Near 52-Week High
The filing occurs while Hinge Health's stock is trading near its 52-week high of $90.91, suggesting the investor is capitalizing on favorable market conditions.
Analysis · HNGE · Technology
Insight Venture Partners, a 10% stockholder, has filed an intent to sell an additional $54 million worth of Hinge Health stock. This follows over $92 million in sales by the same entity in the past three months, bringing their total recent selling activity to over $146 million. This ongoing distribution by a major institutional investor, especially while the stock trades near its 52-week high, could create an overhang on the share price.
At the time of this filing, HNGE was trading at $89.30 on NYSE in the Technology sector, with a market capitalization of approximately $6.9B. The 52-week trading range was $30.08 to $90.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.